Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
Typically, an abnormal liver function test or fatty liver on an ultrasound procedure would highlight the first clue that the liver is not doing well. While multiple non-invasive strategies are being tested and evaluated as potential population screening tools, Prof Dan highlights the liver biopsy as the definitive gold standard diagnosis today after excluding other causes, Although an invasive procedure with minor risk of complications such as bleeding, the liver biopsy is performed for patients who are at risk and whose liver cannot be definitively assessed by non-invasive means
They have many overlapping side effects, especially nausea, vomiting, diarrhea, constipation, and abdominal discomfort
What we dispense is a compounded version, which is not FDA-approved
Benefits of Melanotan MT-I and MT-II have shown various potential benefits, mediated via their respective actions on the melanocortin receptors
While compounded medications are not FDA-approved as brand-name drugs are, they are legally produced under federal oversight and hold the same active pharmaceutical ingredient as Ozempic
